CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to primarily enroll women using the two most widely used global TAVR devices GALWAY, Ireland and WASHINGTON, March 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...
Hence then, the article about smart trial two year data continues to demonstrate superior valve performance for evolut tavr system in small annulus patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients )
Also on site :
- Stunning ISS Photo of Florida, Cuba Captures & 039;Moonglint& 039;
- Saudi-led coalition strikes Yemeni port over unauthorised weapons shipment
- Will Cristiano Ronaldo play tonight for Al-Nassr vs Al Ettifaq in SPL 2025-26?